SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-050505
Filing Date
2018-09-11
Accepted
2018-09-11 16:55:53
Documents
2
Period of Report
2018-09-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4574
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3995
  Complete submission text file 0001209191-18-050505.txt   9954
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Issuer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACLARIS THERAPEUTICS, INC. 101 LINDENWOOD DRIVE, SUITE 400 MALVERN PA 19355
Business Address
Gordon David N. (Reporting) CIK: 0001751167 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37581 | Film No.: 181065321